The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Celluzzi, C. M.
Right arrow Articles by Falo, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Celluzzi, C. M.
Right arrow Articles by Falo, L. D., Jr.
The Journal of Immunology, 1998, 160: 3081-3085.
Copyright © 1998 by The American Association of Immunologists

CUTTING EDGE

Cutting Edge: Physical Interaction Between Dendritic Cells and Tumor Cells Results in an Immunogen That Induces Protective and Therapeutic Tumor Rejection1

Christina M. Celluzzi* and Louis D. Falo, Jr.2,*,{dagger}

* Department of Dermatology and {dagger} University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213

Dendritic cells (DCs) are potent professional APCs capable of presenting Ag in the context of costimulatory signals necessary for T cell activation. Although tumor cells express target Ags, they are generally incapable of stimulating an immune response. We show that the short term physical interaction of DCs and tumor cells, with or without cell fusion, results in rapid, efficient, and stable DC-tumor cell association. Immunization of naive mice with unselected, irradiated DC-tumor cell conjugates induces tumor-specific CD8+ cytotoxic T cells and protection from lethal tumor challenge. Furthermore, the immunogenicity of this cellular vaccine is dependent on the physical interaction of DCs and tumor cells before injection. Immunization with DCs and tumor cells after physical interaction can result in the regression of established tumors and persistent antitumor immunity. These results suggest that immunization with DC-tumor cell vaccines may be a simple, rapid, and potent strategy for tumor immunotherapy.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
J. V. Nayak, D. A. Hokey, A. Larregina, Y. He, R. D. Salter, S. C. Watkins, and L. D. Falo Jr
Phagocytosis Induces Lysosome Remodeling and Regulated Presentation of Particulate Antigens by Activated Dendritic Cells
J. Immunol., December 15, 2006; 177(12): 8493 - 8503.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. Lu, C. Newton, I. Perkins, H. Friedman, and T. W. Klein
Cannabinoid Treatment Suppresses the T-Helper Cell-Polarizing Function of Mouse Dendritic Cells Stimulated with Legionella pneumophila Infection
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 269 - 276.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X.-Y. Chen, W. Zhang, W. Zhang, S. Wu, F. Bi, Y.-J. Su, X.-Y. Tan, J.-N. Liu, and J. Zhang
Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Clin. Cancer Res., October 1, 2006; 12(19): 5834 - 5840.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. A. Hokey, A. T. Larregina, G. Erdos, S. C. Watkins, and L. D. Falo Jr.
Tumor Cell Loaded Type-1 Polarized Dendritic Cells Induce Th1-Mediated Tumor Immunity
Cancer Res., November 1, 2005; 65(21): 10059 - 10067.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. He, J. Zhang, Z. Mi, P. Robbins, and L. D. Falo Jr
Immunization with Lentiviral Vector-Transduced Dendritic Cells Induces Strong and Long-Lasting T Cell Responses and Therapeutic Immunity
J. Immunol., March 15, 2005; 174(6): 3808 - 3817.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Avigan
Dendritic Cell-Tumor Fusion Vaccines for Renal Cell Carcinoma
Clin. Cancer Res., September 15, 2004; 10(18): 6347S - 6352S.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Avigan, B. Vasir, J. Gong, V. Borges, Z. Wu, L. Uhl, M. Atkins, J. Mier, D. McDermott, T. Smith, et al.
Fusion Cell Vaccination of Patients with Metastatic Breast and Renal Cancer Induces Immunological and Clinical Responses
Clin. Cancer Res., July 15, 2004; 10(14): 4699 - 4708.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-C. Yang, S. Hillinger, K. Riedl, L. Zhang, L. Zhu, M. Huang, K. Atianzar, B. Y. Kuo, B. Gardner, R. K. Batra, et al.
Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity
Clin. Cancer Res., April 15, 2004; 10(8): 2891 - 2901.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. T. Larregina, A. E. Morelli, O. Tkacheva, G. Erdos, C. Donahue, S. C. Watkins, A. W. Thomson, and L. D. Falo Jr
Highly efficient expression of transgenic proteins by naked DNA-transfected dendritic cells through terminal differentiation
Blood, February 1, 2004; 103(3): 811 - 819.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Schmidt, C. Ziske, A. Marten, S. Endres, K. Tiemann, V. Schmitz, M. Gorschluter, C. Schneider, T. Sauerbruch, and I. G. H. Schmidt-Wolf
Intratumoral Immunization with Tumor RNA-Pulsed Dendritic Cells Confers Antitumor Immunity in a C57BL/6 Pancreatic Murine Tumor Model
Cancer Res., December 15, 2003; 63(24): 8962 - 8967.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Teitz-Tennenbaum, Q. Li, S. Rynkiewicz, F. Ito, M. A. Davis, C. J. Mcginn, and A. E. Chang
Radiotherapy Potentiates the Therapeutic Efficacy of Intratumoral Dendritic Cell Administration
Cancer Res., December 1, 2003; 63(23): 8466 - 8475.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Wiethe, K. Dittmar, T. Doan, W. Lindenmaier, and R. Tindle
Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-{kappa}B (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen
J. Immunol., October 15, 2003; 171(8): 4121 - 4130.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Wiethe, K. Dittmar, T. Doan, W. Lindenmaier, and R. Tindle
Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen
J. Immunol., March 15, 2003; 170(6): 2912 - 2922.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Berberich, J. R. Ramirez-Pineda, C. Hambrecht, G. Alber, Y. A. W. Skeiky, and H. Moll
Dendritic Cell (DC)-Based Protection Against an Intracellular Pathogen Is Dependent Upon DC-Derived IL-12 and Can Be Induced by Molecularly Defined Antigens
J. Immunol., March 15, 2003; 170(6): 3171 - 3179.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Gong, S. Koido, D. Chen, Y. Tanaka, L. Huang, D. Avigan, K. Anderson, T. Ohno, and D. Kufe
Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
Blood, April 1, 2002; 99(7): 2512 - 2517.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Kotera, K. Shimizu, and J. J. Mule
Comparative Analysis of Necrotic and Apoptotic Tumor Cells As a Source of Antigen(s) in Dendritic Cell-based Immunization
Cancer Res., November 1, 2001; 61(22): 8105 - 8109.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Tong, W. Song, and R. G. Crystal
Combined Intratumoral Injection of Bone Marrow-derived Dendritic Cells and Systemic Chemotherapy to Treat Pre-existing Murine Tumors
Cancer Res., October 1, 2001; 61(20): 7530 - 7535.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Sharma, M. Stolina, L. Zhu, Y. Lin, R. Batra, M. Huang, R. Strieter, and S. M. Dubinett
Secondary Lymphoid Organ Chemokine Reduces Pulmonary Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma
Cancer Res., September 1, 2001; 61(17): 6406 - 6412.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Motta, F. Andre, A. Lim, J. Tartaglia, W. I. Cox, L. Zitvogel, E. Angevin, and P. Kourilsky
Cross-Presentation by Dendritic Cells of Tumor Antigen Expressed in Apoptotic Recombinant Canarypox Virus-Infected Dendritic Cells
J. Immunol., August 1, 2001; 167(3): 1795 - 1802.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. W. Ju, Q. Tao, G. Lou, M. Bai, L. He, Y. Yang, and X. Cao
Interleukin 18 Transfection Enhances Antitumor Immunity Induced by Dendritic Cell-Tumor Cell Conjugates
Cancer Res., May 1, 2001; 61(9): 3735 - 3740.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
L. A. Lambert, G. R. Gibson, M. Maloney, B. Durell, R. J. Noelle, and R. J. Barth Jr.
Intranodal Immunization with Tumor Lysate-pulsed Dendritic Cells Enhances Protective Antitumor Immunity
Cancer Res., January 1, 2001; 61(2): 641 - 646.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
C. Brunner, J. Seiderer, A. Schlamp, M. Bidlingmaier, A. Eigler, W. Haimerl, H.-A. Lehr, A. M. Krieg, G. Hartmann, and S. Endres
Enhanced Dendritic Cell Maturation by TNF-{alpha} or Cytidine-Phosphate-Guanosine DNA Drives T Cell Activation In Vitro and Therapeutic Anti-Tumor Immune Responses In Vivo
J. Immunol., December 1, 2000; 165(11): 6278 - 6286.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. W. Tillman, T. L. Hayes, T. D. deGruijl, J. T. Douglas, and D. T. Curiel
Adenoviral Vectors Targeted to CD40 Enhance the Efficacy of Dendritic Cell-based Vaccination against Human Papillomavirus 16-induced Tumor Cells in a Murine Model
Cancer Res., October 1, 2000; 60(19): 5456 - 5463.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
M. Larsson, D. Messmer, S. Somersan, J.-F. Fonteneau, S. M. Donahoe, M. Lee, P. R. Dunbar, V. Cerundolo, I. Julkunen, D. F. Nixon, et al.
Requirement of Mature Dendritic Cells for Efficient Activation of Influenza A-Specific Memory CD8+ T Cells
J. Immunol., August 1, 2000; 165(3): 1182 - 1190.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Gong, N. Nikrui, D. Chen, S. Koido, Z. Wu, Y. Tanaka, S. Cannistra, D. Avigan, and D. Kufe
Fusions of Human Ovarian Carcinoma Cells with Autologous or Allogeneic Dendritic Cells Induce Antitumor Immunity
J. Immunol., August 1, 2000; 165(3): 1705 - 1711.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Kikuchi, M. A. S. Moore, and R. G. Crystal
Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors
Blood, July 1, 2000; 96(1): 91 - 99.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
S. M. Dubinett, R. K. Batra, P. W. Miller, and S. Sharma
Tumor Antigens in Thoracic Malignancy
Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 524 - 527.
[Full Text]

Home page
 Cancer Res.Home page
F. Henry, O. Boisteau, L. Bretaudeau, B. Lieubeau, K. Meflah, and M. Gregoire
Antigen-presenting Cells That Phagocytose Apoptotic Tumor-derived Cells Are Potent Tumor Vaccines
Cancer Res., July 1, 1999; 59(14): 3329 - 3332.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
H. Su, R. Messer, W. Whitmire, E. Fischer, J. C. Portis, and H. D. Caldwell
Vaccination against Chlamydial Genital Tract Infection after Immunization with Dendritic Cells Pulsed Ex Vivo with Nonviable Chlamydiae
J. Exp. Med., September 7, 1998; 188(5): 809 - 818.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Gong, D. Avigan, D. Chen, Z. Wu, S. Koido, M. Kashiwaba, and D. Kufe
Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells
PNAS, March 14, 2000; 97(6): 2715 - 2718.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.